Showing 401-420 of 503 for: Cochrane Systematic Reviews > Neurologic 
- Rituximab for relapsing-remitting multiple sclerosis
Cochrane Systematic Reviews, 5-Dec-2013
This is an update of the Cochrane review "Rituximab for relapsing-remitting multiple sclerosis" (first published in The Cochrane Library 2011, Issue 12).
- Rivastigmine for Alzheimer's disease
Cochrane Systematic Reviews, 17-Sep-2015
Alzheimer's disease is the commonest cause of dementia affecting older people. One of the therapeutic strategies aimed at ameliorating the clinical manifestations of Alzheimer's disease is to enhance cholinergic neurotransmission in the brain by the use o
- Rivastigmine for vascular cognitive impairment
Cochrane Systematic Reviews, 8-Apr-2013
Vascular dementia represents the second most common type of dementia after Alzheimer's disease. In older patients, in particular, the combination of vascular dementia and Alzheimer's disease is common, and is referred to as mixed dementia. The classificat
- Ropinirole for levodopa-induced complications in Parkinson's disease
Cochrane Systematic Reviews, 16-Dec-2015
Long-term levodopa therapy for Parkinson's disease is complicated by the development of motor fluctuations and abnormal involuntary movements. One approach is to add a dopamine agonist at this stage of the disease to reduce the time the patient spends imm
- Ropinirole versus bromocriptine for levodopa-induced complications in Parkinson's disease
Cochrane Systematic Reviews, 16-Dec-2015
Long-term levodopa therapy for Parkinson's disease is complicated by the development of motor fluctuations and abnormal involuntary movements. One approach is to add a dopamine agonist at this stage of the disease to reduce the time the patient spends imm
- Routine anticonvulsants for treating cerebral malaria
Cochrane Systematic Reviews, 9-Nov-2008
Cerebral malaria is a common complication of Plasmodium falciparum infection, and kills over a million people every year. People with cerebral malaria become unconscious, and often have protracted convulsions. It is unclear whether giving anticonvulsant d
- Routine intracranial pressure monitoring in acute coma
Cochrane Systematic Reviews, 15-Feb-2016
We know that the brain damage resulting from traumatic and other insults is not due solely to the direct consequences of the primary injury. A significant and potentially preventable contribution to the overall morbidity arises from secondary hypoxic-isch
- Routine surgery in addition to chemotherapy for treating spinal tuberculosis
Cochrane Systematic Reviews, 29-Apr-2013
Tuberculosis is generally curable with chemotherapy, but there is controversy in the literature about the need for surgical intervention in the one to two per cent of people with tuberculosis of the spine.
- Sapropterin dihydrochloride for phenylketonuria
Cochrane Systematic Reviews, 25-Mar-2015
Phenylketonuria results from a deficiency of the enzyme phenylalanine hydroxylase. Dietary restriction of phenylalanine keeps blood phenylalanine concentration low. Most natural foods are excluded from diet and supplements are used to supply other nutrien
- Scapular fixation in muscular dystrophy
Cochrane Systematic Reviews, 10-May-2011
Winging of the scapula is caused by weakness of the thoracoscapular muscles, which allows the scapula to lift off the chest wall during shoulder movements. In facioscapulohumeral muscular dystrophy (and occasionally in other muscular dystrophies) there is
- Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults
Cochrane Systematic Reviews, 30-Apr-2015
This is an updated version of the original Cochrane review published in 2005 on selective serotonin reuptake inhibitors (SSRIs) for preventing migraine and tension-type headache. The original review has been split in two parts and this review now only reg
- Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)
Cochrane Systematic Reviews, 8-Aug-2013
Autism spectrum disorders (ASD) are characterised by abnormalities in social interaction and communication skills, as well as stereotypic behaviours and restricted activities and interests. Selective serotonin reuptake inhibitors (SSRIs) are prescribed fo
- Selegiline for Alzheimer's disease
Cochrane Systematic Reviews, 12-May-2008
Alzheimer's disease is the most common cause of dementia in older people accounting for some 60% of cases with late-onset cognitive deterioration. It is now thought that several neurotransmitter dysfunctions are involved from an early stage in the pathoge
- Sensory stimulation for brain injured individuals in coma or vegetative state
Cochrane Systematic Reviews, 22-Sep-2008
Coma and vegetative state follow traumatic brain injury in about one out of eight patients, and in patients with non traumatic injury the prognosis is worse. The use of sensory stimulation for coma and vegetative state has gained popularity during the 198
- Shunting for normal pressure hydrocephalus (NPH)
Cochrane Systematic Reviews, 8-Sep-2008
Since the condition was first described in 1965, the syndrome of normal pressure hydrocephalus (NPH) has conventionally been managed by placement of a cerebrospinal fluid (CSF) shunt.
- Single dose oral mefenamic acid for acute postoperative pain in adults
Cochrane Systematic Reviews, 14-Sep-2011
Mefenamic acid is a non-steroidal anti-inflammatory drug (NSAID). It is most often used for treating pain of dysmenorrhoea in the short term (seven days or less), as well as mild to moderate pain including headache, dental pain, postoperative and postpart
- Snoezelen for dementia
Cochrane Systematic Reviews, 7-Oct-2008
Snoezelen, multi-sensory stimulation, provides sensory stimuli to stimulate the primary senses of sight, hearing, touch, taste and smell, through the use of lighting effects, tactile surfaces, meditative music and the odour of relaxing essential oils. The
- Special care units for dementia individuals with behavioural problems
Cochrane Systematic Reviews, 12-Apr-2012
The behavioural problems of people with dementia are often considered as one of the most challenging issues in caring. Special Care Units (SCUs) have flourished since the 1980s with the aim of taking care of dementia patients, usually those with Alzheimer
- Speech and language therapy for aphasia following stroke
Cochrane Systematic Reviews, 5-Apr-2012
Aphasia is an acquired language impairment following brain damage that affects some or all language modalities: expression and understanding of speech, reading and writing. Approximately one-third of people who have a stroke experience aphasia.
- Speech and language therapy for dysarthria due to non-progressive brain damage
Cochrane Systematic Reviews, 1-Oct-2008
Dysarthria is a common sequel of non-progressive brain damage (typically stroke and traumatic brain damage). Impairment-based therapy and a wide variety of compensatory management strategies are undertaken by speech and language therapists with this patie
